- Amelia Gooch1
- Silver Chain1
1995
ExcerptIn recent times there has been publicity related to the use of Ketorolac on a long-term basis due to the potential side effects of this drug.
The management of pain related to bone disease is renowned for being one of the most difficult types of pain to control.
Many terminally ill patients have already completed courses of radiotherapy and chemotherapy, and may also have been treated with anti-inflammatory medications. These treatments can cause gastric irritation, which limit the choice of medications as disease progresses.
Disease process may also cause renal and hepatic impairment which further limit choice in pain management.
In this report we will present our experiences with the use of Ketorolac in the form of subcutaneous doses in stat dosage, 5-day courses and by syringe driver. The results varied between no pain relief obtained, to marked pain relief with reduction of narcotics.
Ketorolac is an alternative anti-inflammatory medication which is worth consideration when other treatments have failed to be effective in bone pain management.